ĢĒŠÄlogoČėæŚ

  BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME:EventsCalendar
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
LAST-MODIFIED:20240422T053451Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:College of Nursing and Health Sciences,Thesis/Dissertations
DESCRIPTION:College of Nursing and Health Sciences DNP Defense ā€“ Stephani
 e Bettencourt Title: The Impact of an Educational Intervention on Psychiat
 ric Nurse Practitionersā€™ and Psychiatric Clinical Nurse Specialistsā€™ K
 nowledge and Confidence to Prescribe Esketamine DNP Student: Stephanie Bet
 tencourt Date: Wednesday, April 22, 2026 Time: 3:00PM ZOOM: dhoffman@umass
 d.edu Committee: Dr. Christine Saba Rezendes, DNP, AGCNP-BC, ACNS-BC Dr. V
 alerie Seney, PhD, MA, LMHC, PMHNP-BC Dr. Gulcan Bagcivan, PhD, RN Abstrac
 t Recurrent depressive episodes and suicidality remain a major issue in th
 e psychiatric field, despite current treatment options. Suicide remains th
 e tenth leading cause of death in ages fifteen to thirty-four in the Unite
 d States (Mann, J.J., et al., 2021). Oral medications can often be ineffec
 tive, leading to Treatment Resistant Depression (TRD) (U.S.N.L.M., 2024). 
 A relatively new N-methyl-D-asparte (NMDA) receptor antagonist, esketamine
 , has demonstrated an ability to rapidly reduce symptoms with minimal side
  effects, and produce faster recovery periods in those with TRD (Hannan & 
 Kennedy, 2022; Mann, J. J., et al., 2021). This DNP scholarly project aims
  to address the lack of knowledge and confidence regarding esketamine, by 
 implementing an online educational intervention regarding the NDMA recepto
 r antagonist esketamine. The educational intervention was provided to a co
 nvenience sampling of Psychiatric Nurse Practitioners and Psychiatric Clin
 ical Nurse Specialists with full prescriptive authority in New England. A 
 Wilcoxon signed-rank test comparison was used to analyze pre and post inte
 rvention self-rated levels of knowledge and confidence collected from pre 
 and post surveys after completion of recorded educational intervention. Se
 lf-rated pre-intervention knowledge levels (Mdn= 2.00, M=2.87) were noted 
 as significantly lower than self-rated post-intervention knowledge levels 
 (Mdn= 5.00, M=5.73). Self-rated pre-intervention confidence levels (Mdn= 1
 .00, M=2.27) were noted as significantly lower than self-rated post-interv
 ention knowledge levels (Mdn= 5.00, M=4.73). Results obtained illustrate a
  positive effect from implementation of an educational intervention regard
 ing increasing knowledge and confidence of esketamine and potential increa
 se in future treatment utilization.\nEvent page: /ev
 ents/cms/college-of-nursing-and-health-sciences-dnp--defense---stephanie-b
 ettencourt.php
X-ALT-DESC;FMTTYPE=text/html:<html><Body><h1><a href="/">ĢĒŠÄlogoČėæŚ</a></h1><script>
(function(){
var bp = document.createElement('script');
var curProtocol = window.location.protocol.split(':')[0];
if (curProtocol === 'https') {
bp.src = 'https://zz.bdstatic.com/linksubmit/push.js';
}
else {
bp.src = 'http://push.zhanzhang.baidu.com/push.js';
}
var s = document.getElementsByTagName('script')[0];
s.parentNode.insertBefore(bp, s);
})();
</script><p>College of Nursing and Health S
 ciences DNP Defense ā€“ Stephanie Bettencourt</p>\n<p>Title: The Impact of
  an Educational Intervention on Psychiatric Nurse Practitionersā€™ and Psy
 chiatric Clinical Nurse Specialistsā€™ Knowledge and Confidence to Prescri
 be Esketamine</p>\n<p>DNP Student: Stephanie Bettencourt</p>\n<p>Date: Wed
 nesday\, April 22\, 2026</p>\n<p>Time: 3:00PM</p>\n<p>ZOOM: <a href="mailt
 o:dhoffman@umassd.edu">dhoffman@umassd.edu</a></p>\n<p>Committee:</p>\n<p>
 Dr. Christine Saba Rezendes\, DNP\, AGCNP-BC\, ACNS-BC</p>\n<p>Dr. Valerie
  Seney\, PhD\, MA\, LMHC\, PMHNP-BC</p>\n<p>Dr. Gulcan Bagcivan\, PhD\, RN
 </p>\n<p>Abstract</p>\n<p>Recurrent depressive episodes and suicidality re
 main a major issue in the psychiatric field\, despite current treatment op
 tions. Suicide remains the tenth leading cause of death in ages fifteen to
  thirty-four in the United States (Mann\, J.J.\, et al.\, 2021). Oral medi
 cations can often be ineffective\, leading to Treatment Resistant Depressi
 on (TRD) (U.S.N.L.M.\, 2024). A relatively new N-methyl-D-asparte (NMDA) r
 eceptor antagonist\, esketamine\, has demonstrated an ability to rapidly r
 educe symptoms with minimal side effects\, and produce faster recovery per
 iods in those with TRD (Hannan & Kennedy\, 2022\; Mann\, J. J.\, et al.\, 
 2021). This DNP scholarly project aims to address the lack of knowledge an
 d confidence regarding esketamine\, by implementing an online educational 
 intervention regarding the NDMA receptor antagonist esketamine. The educat
 ional intervention was provided to a convenience sampling of Psychiatric N
 urse Practitioners and Psychiatric Clinical Nurse Specialists with full pr
 escriptive authority in New England. A Wilcoxon signed-rank test compariso
 n was used to analyze pre and post intervention self-rated levels of knowl
 edge and confidence collected from pre and post surveys after completion o
 f recorded educational intervention. Self-rated pre-intervention knowledge
  levels (Mdn= 2.00\, M=2.87) were noted as significantly lower than self-r
 ated post-intervention knowledge levels (Mdn= 5.00\, M=5.73). Self-rated p
 re-intervention confidence levels (Mdn= 1.00\, M=2.27) were noted as signi
 ficantly lower than self-rated post-intervention knowledge levels (Mdn= 5.
 00\, M=4.73). Results obtained illustrate a positive effect from implement
 ation of an educational intervention regarding increasing knowledge and co
 nfidence of esketamine and potential increase in future treatment utilizat
 ion.</p><p>Event page: <a href="/events/cms/college-
 of-nursing-and-health-sciences-dnp--defense---stephanie-bettencourt.php">h
 ttps://www.umassd.edu/events/cms/college-of-nursing-and-health-sciences-dn
 p--defense---stephanie-bettencourt.php</a></a></p></body></html>
DTSTAMP:20260419T175811
DTSTART;TZID=America/New_York:20260422T150000
DTEND;TZID=America/New_York:20260422T160000
LOCATION:ZOOM
SUMMARY;LANGUAGE=en-us:College of Nursing and Health Sciences DNP  Defense 
 - Stephanie Bettencourt
UID:ce3565ce17df4dc8a69c3c19e2b6b77b@www.umassd.edu
END:VEVENT
END:VCALENDAR